SK

Shiju Kolathuparambil Ramakrishnan

Director Director DIN 06806449
DIN 06806449 First appointment Feb 2014 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Shiju Kolathuparambil Ramakrishnan

Data last updated:

Shiju Kolathuparambil Ramakrishnan was a Director at Mattathur Institute Of Medical Sciences And Research Centre Private Limited (2014–2016). The company operates in Healthcare.

DIN 06806449
Primary Designation Director
Industry Healthcare
First Appointment 18 Feb 2014

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Feb 20142014₹19.3 Lakh (FY 2019)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mattathur Institute Of Medical Sciences And Research Centre Private Limited
Premium access

Shareholding and investment profile for Shiju Kolathuparambil Ramakrishnan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shiju Kolathuparambil Ramakrishnan

Shiju Kolathuparambil Ramakrishnan was first appointed on 18 Feb 2014 as Director at Mattathur Institute Of Medical Sciences And Research Centre Private Limited.

Shiju Kolathuparambil Ramakrishnan held 1 earlier board appointment: Mattathur Institute Of Medical Sciences And Research Centre Private Limited (Director, 18 Feb 2014 to 30 Sep 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available